PMI Submits PMTA for IQOS ILUMA Heated Tobacco Product
According to a report by Yahoo Finance on October 20, Philip Morris International (PMI) has submitted a Pre-Market Tobacco Product Application (PMTA) and a Modified Risk Tobacco Product Application (MRTPA) to the US Food and Drug Administration (FDA) for its IQOS ILUMA heated tobacco product.
In order to sell their new tobacco products in the United States, PMI needs to obtain PMTA approval. The company is also seeking permission to market the IQOS ILUMA product as an improved risk product that reduces exposure to harmful and potentially harmful chemicals, just like the previous versions of IQOS which were granted this status.
The following are the key details released by PMI:
Unlike traditional cigarettes, IQOS products heat but do not burn tobacco. The IQOS ILUMA product is the most innovative heated tobacco product from PMI. In comparison to the previously FDA authorized versions of IQOS, they show a significant reduction in the formation of harmful and potentially harmful constituents. IQOS ILUMA demonstrates higher overall conversion rates and improved consumer satisfaction among adult smokers in various countries worldwide. This product relies on a completely different heating technology from previous versions of IQOS and includes several technological advancements, such as improved device and battery life. IQOS ILUMA is currently available in 27 international markets. PMI's application is supported by thorough scientific evaluations, including aerosol chemistry, in vitro toxicology, pharmacokinetic studies, consumer perception and behavior research, and comprehensive scientific data collected from the previous version of the IQOS system. The IQOS ILUMA device operates on the SMARTCORE induction system, which internally heats tobacco through the use of TEREA SMARTCORE pods designed exclusively for use with the IQOS ILUMA device. PMI has submitted applications for three ILUMA devices and five pods: TEREA BLUE, TEREA GREEN, TEREA SIENNA, TEREA BRONZE, and TEREA AMBER.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
